SCHEMBL27179686

SCHEMBL27179686

Cc1ccc(S(=O)(=O)Nc2cccc(C(=O)Nc3cccc(C(=O)NC4CC4)c3)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.64
▸ HTT P42858 2/20 0.64
▸ CYP1A2 P05177 1/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ CYP2D6 P10635 1/20 0.64
▸ CYP2C9 P11712 1/20 0.64
▸ CYP2C19 P33261 1/20 0.64
▸ RECQL P46063 1/20 0.64
▸ MEN1 O00255 7/20 0.61
▸ KMT2A Q03164 7/20 0.61
▸ LMNA P02545 1/20 0.60
▸ TCF4 P15884 1/20 0.59
▸ CTNNB1 P35222 1/20 0.59
▸ ADRB2 P07550 1/20 0.58
▸ KDM1A O60341 1/20 0.56
▸ EGFR P00533 3/20 0.55
▸ FGFR1 P11362 3/20 0.55
▸ KDR P35968 3/20 0.55
▸ SMYD3 Q9H7B4 1/20 0.54
▸ PKM P14618 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179484 0.90 ADRB2 (0.67) MAPTMEN1KMT2ALMNAADRB2
SCHEMBL27179714 0.86 MEN1 (0.76) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL30927044 0.86 MEN1 (0.76) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL27180182 0.86 KMT2A (0.57) MAPTHTTMEN1KMT2ALMNA
SCHEMBL7595950 0.82 ADORA3 (0.64) HTTCYP1A2CYP2C19MEN1KMT2A
SCHEMBL6322069 0.82 ADORA3 (0.64) HTTCYP1A2CYP2C19MEN1KMT2A
SCHEMBL6329898 0.81 ALDH1A1 (0.65) HTTCYP1A2CYP2C19MEN1KMT2A
SCHEMBL6959526 0.79 TCF4 (0.75) MAPTHTTCYP1A2CYP3A4CYP2D6
SCHEMBL11025715 0.79 POLB (0.78) MAPTMEN1KMT2ATCF4CTNNB1
SCHEMBL30926644 0.79 MAPT (0.72) MAPTHTTCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MAPT 4236/4885HTT 4627/4885CYP1A2 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback